Personal information

Other IDs

ResearcherID: K-4013-2015

Activities

Collapse all

Employment (2)

Rutgers New Jersey Medical School: Newark, NJ, US

2002 to present | Professor (Microbiology, Biochemistry and Molecular Genetics)
Employment
Source: Self-asserted source
David Perlin

Public Health Research Institute: Newark, NJ, US

1985 to present | Executive Director and Professor
Employment
Source: Self-asserted source
David Perlin

Education and qualifications (2)

Yale University School of Medicine: New Haven, CT, US

1980 to 1983 | Pstdoctoral
Education
Source: Self-asserted source
David Perlin

Cornell University: Ithaca, NY, US

1976 to 1980 | PhD (Plant Biology)
Education
Source: Self-asserted source
David Perlin

Funding (9)

Critical Factors Influencing Echinocandin Resistance in Candida glabrata

2014-08-01 to 2018-07-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 1R01AI109025-01
GRANT_NUMBER: 1R01AI109025-01
Source: Self-asserted source
David Perlin via DimensionsWizard

Center to develop therapeutic countermeasures to high-threat bacterial agents

2014-04-25 to 2019-03-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 5U19AI109713-02
GRANT_NUMBER: 5U19AI109713-02
Source: Self-asserted source
David Perlin via DimensionsWizard

Linking Triazole Resistance and Fitness in Aspergillus fumigatus

2013-04-15 to 2015-03-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 5R21AI103636-03
GRANT_NUMBER: 5R21AI103636-03
Source: Self-asserted source
David Perlin via DimensionsWizard

Mechanism of clinical resistance to echinocandin antifungal drugs

2007-06-18 to 2014-05-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 6R01AI069397-06
GRANT_NUMBER: 6R01AI069397-06
Source: Self-asserted source
David Perlin via DimensionsWizard

A Rapid and Expandable Nucleic Acid Platform to Detect Bloodstream Infections

2005-07-14 to 2011-03-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 5U01AI066561-06
GRANT_NUMBER: 5U01AI066561-06
Source: Self-asserted source
David Perlin via DimensionsWizard

Rapid Evaluation of Drug Resistance in Pathogenic Fungi

2003-04-15 to 2005-03-31 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 5R21AI055767-02
GRANT_NUMBER: 5R21AI055767-02
Source: Self-asserted source
David Perlin via DimensionsWizard

CANDIDA PROTON PUMP--AN IMPORTANT MOLECULAR TARGET

1993-12-01 to 1996-11-30 | Grant
National Institute of Allergy and Infectious Diseases (Bethesda, US)
GRANT_NUMBER: 5R01AI035411-03
GRANT_NUMBER: 5R01AI035411-03
Source: Self-asserted source
David Perlin via DimensionsWizard

ENERGY COUPLING BY THE YEAST PLASMA MEMBRANE H+_ATPASE

1987-04-01 to 2004-11-30 | Grant
National Institute of General Medical Sciences (Bethesda, US)
GRANT_NUMBER: 5R01GM038225-17
GRANT_NUMBER: 5R01GM038225-17
Source: Self-asserted source
David Perlin via DimensionsWizard

Evaluation of Carbohydrate-Derived Fulvic Acid (CHD-FA) as a Topical Broad-Spectrum Antimicrobial for Drug-Resistant Wound Infections

Grant
Congressionally Directed Medical Research Programs (n/a, US)
GRANT_NUMBER:

W81XWH1220076

GRANT_NUMBER: W81XWH1220076
Source: Self-asserted source
David Perlin via DimensionsWizard
How many people are using ORCID?